Status: current, Defined. Date: 31-Mar 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1562551000168116 | Actair Continuation Treatment 300 IR (American house dust mite extract (Dermatophagoides farinae) 150 IR + European house dust mite extract (Dermatophagoides pteronyssinus) 150 IR) sublingual tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1562561000168119 | Actair Continuation Treatment 300 IR sublingual tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Actair Continuation Treatment 300 IR sublingual tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Actair Continuation Treatment 300 IR sublingual tablet | Is a | Actair Continuation Treatment 300 IR | true | Inferred relationship | Some | ||
| Actair Continuation Treatment 300 IR sublingual tablet | Is a | American house dust mite extract + European house dust mite extract (total 300 IR) sublingual tablet | true | Inferred relationship | Some | ||
| Actair Continuation Treatment 300 IR sublingual tablet | has manufactured dose form | sublingual tablet | true | Inferred relationship | Some | ||
| Actair Continuation Treatment 300 IR sublingual tablet | has unit of use | tablet | true | Inferred relationship | Some | 2037218551 | |
| Actair Continuation Treatment 300 IR sublingual tablet | has Australian BoSS | European house dust mite extract | true | Inferred relationship | Some | 2037218550 | |
| Actair Continuation Treatment 300 IR sublingual tablet | has intended active ingredient | European house dust mite extract | true | Inferred relationship | Some | 2037218550 | |
| Actair Continuation Treatment 300 IR sublingual tablet | has Australian BoSS | American house dust mite extract | true | Inferred relationship | Some | 639721726 | |
| Actair Continuation Treatment 300 IR sublingual tablet | has intended active ingredient | American house dust mite extract | true | Inferred relationship | Some | 639721726 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Actair Continuation Treatment 300 IR sublingual tablet, 30, blister pack | has TPUU | True | Actair Continuation Treatment 300 IR sublingual tablet | Inferred relationship | Some | 1 |
| Actair Continuation Treatment 300 IR sublingual tablet, 90, blister pack | has TPUU | True | Actair Continuation Treatment 300 IR sublingual tablet | Inferred relationship | Some | 1 |
| Actair Continuation Treatment 300 IR sublingual tablet, 90 | has TPUU | True | Actair Continuation Treatment 300 IR sublingual tablet | Inferred relationship | Some | 1 |
| Actair Continuation Treatment 300 IR sublingual tablet, 30 | has TPUU | True | Actair Continuation Treatment 300 IR sublingual tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR